Qube Research & Technologies (QRT)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-172,189
Closed -$2.57M 3764
2024
Q4
$2.57M Buy
+172,189
New +$2.81M ﹤0.01% 1779
2024
Q1
Sell
-1,431,795
Closed -$20.6M 4754
2023
Q4
$20.6M Buy
1,431,795
+1,254,374
+707% +$17.1M 0.04% 501
2023
Q3
$3.08M Buy
+177,421
New +$3.7M 0.01% 1165
2022
Q4
Sell
-559,690
Closed -$13.1M 2844
2022
Q3
$13.1M Buy
559,690
+487,076
+671% +$14.7M 0.08% 342
2022
Q2
$2.45M Buy
72,614
+7,910
+12% +$277K 0.02% 734
2022
Q1
$2.26M Sell
64,704
-128,630
-67% -$4.4M 0.02% 771
2021
Q4
$5.89M Buy
193,334
+171,721
+795% +$5.59M 0.05% 503
2021
Q3
$709K Sell
21,613
-7,387
-25% -$236K 0.01% 1043
2021
Q2
$878K Buy
+29,000
New +$955K 0.01% 1002

Other funds holding OGN

Qube Research & Technologies (QRT)'s OGN Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 172,189 shares — an estimated $2.57M sold.

Qube Research & Technologies (QRT) first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $20.6M in Q4 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 172,189 Organon & Co shares in Q1 2025, an estimated $2.57M.
  • Qube Research & Technologies (QRT) first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Organon & Co position peaked at $20.6M in Q4 2023.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.